GlassScriptPhysician profile
Jason S Wolff
NPI 1376759845
$8,603.74
in general payments reported to CMS, 2019-2025
21 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,087 · 2020: $969 · 2021: $2,561 · 2022: $2,825 · 2023: $424 · 2024: $329 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104 · Travel and Lodging: $57.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.79 |
| Travel and Lodging | $57.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,103.64 | 2021-2025 | Venaseal, Kyphon Express II Kyphopak Tray, Inceptiv |
| Nevro Corp. | $991.84 | 2019-2024 | Senza |
| Relievant Medsystems, INC. | $829.68 | 2020-2023 | Intracept |
| Abbott Laboratories | $629.42 | 2019-2022 | |
| Medtronic USA, INC. | $466.32 | 2019-2020 | |
| Si-Bone, INC. | $413.31 | 2019-2022 | |
| Boston Scientific Corporation | $411.50 | 2019-2024 | |
| Biotronik Nro, INC. | $333.16 | 2025 | Prospera |
| Saluda Medical Americas, INC. | $175.05 | 2022-2025 | Evoke |
| Vertos Medical, INC. | $48.70 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $36.97 | 2019 | |
| Ferring Pharmaceuticals INC. | $34.88 | 2020-2021 | |
| Electronic Waveform Lab, INC. | $18.12 | 2019 | |
| Bioventus LLC | $16.79 | 2019 | |
| Upsher-Smith Laboratories LLC | $16.49 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $14.36 | 2022 | |
| Depuy Synthes Sales INC. | $14.33 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $12.67 | 2021 | |
| Amgen INC. | $12.50 | 2021 | |
| Biodelivery Sciences International, INC. | $12.49 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.